Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases, as well as collaboration with Bicycle Therapeutics to develop bicyclic peptides. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

0P6S.L

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

0QLR.L

HKSE

1093.HK

2186.HK

XETRA

4AB.DE

6MK.DE

ABBOTINDIA.NS

AbbVie Inc is an American multinational biopharmaceutical company based in North Chicago, Illinois. It was created in 2013 as a spin-off of Abbott Laboratories. AbbVie is focused on developing and marketing advanced therapies for severe and chronic conditions, emphasizing oncology, immunology, and virology.

NYSE

ABBV

Other OTC

ALPMY

AMG.DE

NasdaqGS

AMGN

AstraZeneca plc, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc, as well as research collaboration with Sernova Corp. to evaluate novel potential therapeutic cell applications. The company was formerly known as Zeneca Group plc and changed its name to AstraZeneca plc in April 1999. AstraZeneca plc was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

AZN.L

BAYN.DE

BAYRY

BIIB

Bristol-Myers Squibb Company (BMY) is a multinational pharmaceutical company that specializes in developing, manufacturing, and marketing prescription drugs and biologic products. The company has a diverse portfolio of products, including cancer and cardiovascular disease treatments. BMS is headquartered in New York City and operates globally, with a strong presence in both developed and emerging markets.

BRM.DE

CHGCY

CIPLA.NS

Drug Manufacturers - General

Symbol	Full Name	Sector	Industry	YTD Return	10Y Return (Annualized)	Dividend Yield
0P6S.L	Bayer AG NA	Healthcare	Drug Manufacturers - General	-17.75%	-9.23%	0.40%
0QLR.L	Novartis AG	Healthcare	Drug Manufacturers - General	15.19%	4.36%	0.03%
1093.HK	CSPC Pharmaceutical Group Ltd	Healthcare	Drug Manufacturers - General	-17.88%	8.00%	4.79%
2186.HK	Luye Pharma Group Ltd	Healthcare	Drug Manufacturers - General	-26.54%	-8.10%	0.00%
4AB.DE	AbbVie Inc	Healthcare	Drug Manufacturers - General	23.64%	20.43%	3.65%
6MK.DE	Merck & Co. Inc	Healthcare	Drug Manufacturers - General	21.24%	15.04%	2.59%
ABBOTINDIA.NS	Abbott India Limited	Healthcare	Drug Manufacturers - General	24.36%	31.51%	1.46%
ABBV	AbbVie Inc.	Healthcare	Drug Manufacturers - General	20.88%	17.79%	3.36%
ALPMY	Astellas Pharma Inc	Healthcare	Drug Manufacturers - General	-10.11%	-0.90%	0.00%
AMG.DE	Amgen Inc	Healthcare	Drug Manufacturers - General	21.96%	16.64%	2.80%
AMGN	Amgen Inc.	Healthcare	Drug Manufacturers - General	17.81%	13.70%	2.62%
AZN	AstraZeneca PLC	Healthcare	Drug Manufacturers - General	18.38%	11.48%	1.85%
AZN.L	AstraZeneca plc	Healthcare	Drug Manufacturers - General	15.56%	14.45%	0.02%
BAYN.DE	Bayer Aktiengesellschaft	Healthcare	Drug Manufacturers - General	-17.81%	-8.94%	0.40%
BAYRY	Bayer AG PK	Healthcare	Drug Manufacturers - General	-19.35%	-10.40%	0.39%
BIIB	Biogen Inc.	Healthcare	Drug Manufacturers - General	-12.11%	-3.05%	0.00%
BMY	Bristol-Myers Squibb Company	Healthcare	Drug Manufacturers - General	-8.34%	2.14%	5.24%
BRM.DE	Bristol-Myers Squibb Company	Healthcare	Drug Manufacturers - General	-5.67%	6.46%	5.67%
CHGCY	Chugai Pharmaceutical Co Ltd ADR	Healthcare	Drug Manufacturers - General	7.41%	22.83%	0.65%
CIPLA.NS	Cipla Limited	Healthcare	Drug Manufacturers - General	20.00%	13.87%	0.00%

Drug Manufacturers - General Stock List